Get the Stockscreener App
14.33
1.27%
0.18
Mbx Biosciences Inc stock is traded at $14.33, with a volume of 280.07K.
It is up +1.27% in the last 24 hours and up +22.48% over the past month.
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.
See More
Previous Close:
$14.15
Open:
$14.35
24h Volume:
280.07K
Relative Volume:
0.77
Market Cap:
$481.40M
Revenue:
-
Net Income/Loss:
$-47.20M
P/E Ratio:
-9.1548
EPS:
-1.5653
Net Cash Flow:
$-43.65M
1W Performance:
-2.62%
1M Performance:
+22.48%
6M Performance:
+31.71%
1Y Performance:
+0.00%
1-Day Range:
$13.91
$15.04
1-Week Range:
$12.86
$15.04
52-Week Range:
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
Name
Mbx Biosciences Inc
Sector
Industry
Phone
(317) 989-3100
Address
11711 N. MERIDIAN STREET, CARMEL
Compare MBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
14.33 | 489.46M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Resumed | Jefferies | Buy |
| Aug-05-25 | Initiated | Mizuho | Outperform |
| Jul-16-25 | Initiated | Oppenheimer | Outperform |
| Apr-10-25 | Initiated | Citizens JMP | Mkt Outperform |
| Oct-08-24 | Initiated | Guggenheim | Buy |
| Oct-08-24 | Initiated | JP Morgan | Overweight |
| Oct-08-24 | Initiated | Jefferies | Buy |
| Oct-08-24 | Initiated | Stifel | Buy |
View All
Mbx Biosciences Inc Stock (MBX) Latest News
MBX Biosciences Insiders Added US$579.8k Of Stock To Their Holdings - Yahoo Finance
Screener Results Flag MBX Biosciences Inc. as OversoldTrade Risk Summary & Long-Term Growth Portfolio Plans - mustnews.co.kr
MBX Biosciences Submits IND for Once-Monthly Obesity Drug - MSN
Forecasting MBX Biosciences Inc. price range with options dataBear Alert & Daily Entry Point Trade Alerts - Newser
How to recover losses in MBX Biosciences Inc. stockTrade Volume Summary & Accurate Trade Setup Notifications - Newser
Volume Profile Shows Strong Base for MBX Biosciences Inc.July 2025 Trends & Capital Efficient Trade Techniques - thegnnews.com
Can swing trading help recover from MBX Biosciences Inc. lossesWeekly Trade Report & Smart Investment Allocation Tips - Newser
Breakout Traders Target MBX Biosciences Inc. on Recovery SetupWeekly Profit Report & Stock Portfolio Risk Management - newsimpact.co.kr
What to do if you’re stuck in MBX Biosciences Inc.July 2025 Macro Moves & Free Technical Pattern Based Buy Signals - Newser
What makes MBX Biosciences Inc. stock price move sharplyTrade Volume Summary & Weekly Market Pulse Alerts - thegnnews.com
Is MBX Biosciences Inc. a strong growth stock2025 Geopolitical Influence & Accurate Buy Signal Notifications - thegnnews.com
MBX Biosciences Inc. recovery potential after sell offPortfolio Update Summary & Reliable Entry Point Trade Alerts - Newser
How to track smart money flows in MBX Biosciences Inc.Take Profit & Risk Adjusted Buy and Sell Alerts - Newser
Can a trend reversal in MBX Biosciences Inc. lead to recovery2025 Market Overview & Fast Moving Stock Watchlists - Newser
MBX Biosciences stock rating initiated at Buy by Jefferies with $36 target - Investing.com
When is the best time to exit MBX Biosciences Inc.2025 Winners & Losers & Safe Swing Trade Setup Alerts - Newser
Jefferies Maintains "Buy" Rating for MBX Biosciences with $36 Price Target. - AInvest
What is MBX Biosciences Inc.’s book value per share2025 Historical Comparison & Long-Term Growth Stock Strategies - thegnnews.com
MBX Biosciences assumed with a Buy at Jefferies - TipRanks
MBX Biosciences (MBX) and Its Competitors Critical Survey - Defense World
Published on: 2025-08-14 21:34:07 - Newser
Options Data Show Bullish Bias in MBX Biosciences Inc.July 2025 Price Swings & Expert Verified Stock Movement Alerts - kangso.co.kr
What’s next for MBX Biosciences Inc. stock priceJuly 2025 Price Swings & Weekly Hot Stock Watchlists - Newser
How to use a screener to detect MBX Biosciences Inc. breakoutsJuly 2025 Gainers & Weekly Breakout Opportunity Watchlist - Newser
MBX Biosciences (MBX) and The Competition Head to Head Survey - Defense World
Is MBX Biosciences Inc. stock a good hedge against inflationBear Alert & Detailed Earnings Play Strategies - Newser
Can volume confirm reversal in MBX Biosciences Inc.Market Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Volatility clustering patterns for MBX Biosciences Inc.July 2025 Highlights & Free Risk Controlled Daily Trade Plans - Newser
Applying big data sentiment scoring on MBX Biosciences Inc.Weekly Loss Report & Weekly High Return Forecasts - Newser
MBX Biosciences, Inc. (NYSE:MBX) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Can trapped investors hope for a rebound in MBX Biosciences Inc. [2025 Trading Recap]Free Daily Stock Trend Watchlist - Newser
MBX Biosciences Triggers Bullish KDJ Golden Cross and Marubozu - AInvest
Using economic indicators to assess MBX Biosciences Inc. potentialSector-Wise Equity Performance Trend Forecast - Newser
MBX Biosciences Reports Progress and Financial Stability - TipRanks
Tools to assess MBX Biosciences Inc.’s risk profileTriple Digit Gain Opportunity Watchlist - Newser
Technical signs of recovery in MBX Biosciences Inc.Free Reliable Investment Entry Point Signals - Newser
Can trapped investors hope for a rebound in MBX Biosciences Inc.Free Market Surge Signal for Swing Traders - Newser
How does MBX Biosciences Inc. compare to its peers3x ROI Investment Watch - thegnnews.com
MBX Biosciences (NYSE:MBX) Earns Outperform Rating from Analysts at Mizuho - MarketBeat
Technical analysis overview for MBX Biosciences Inc. stockMachine Learning Intraday Signal Forecast - Newser
Is MBX Biosciences Inc. forming a reversal patternSwing Trade Picks with High Potential - Newser
Mbx Biosciences Inc Stock (MBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mbx Biosciences Inc Stock (MBX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director |
Feb 18 '25 |
Buy |
10.84 |
143,170 |
1,551,963 |
3,255,000 |
| GORDON CARL L | Director |
Feb 14 '25 |
Buy |
9.87 |
47,502 |
468,793 |
3,205,930 |
| ORBIMED ADVISORS LLC | Director |
Feb 18 '25 |
Buy |
10.84 |
143,170 |
1,551,963 |
3,255,000 |
| ORBIMED ADVISORS LLC | Director |
Feb 14 '25 |
Buy |
9.87 |
47,502 |
468,793 |
3,205,930 |
| Hawryluk P. Kent | President & CEO |
Feb 04 '25 |
Buy |
10.69 |
50,000 |
534,500 |
448,277 |
| Mathers Edward T | Director |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| BASKETT FOREST | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Behbahani Ali | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Chang Carmen | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Florence Anthony A. Jr. | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):